← Stock Trading Canary · All insider profiles
INSIDER PROFILE · FR
TRUFFLE CAPITAL SAS
Philippe POULETTY, Directeur Général Truffle Capital
Profile key: fr|truffle capital sas
Purchase history
- Companies traded
- 2
- Purchases · 12M
- 4
- Purchases · 24M
- 5
- Average purchase
- €1,529,399
- Gross purchase value
- €7,646,994
- Last purchase
- 2026-06-26
- Completed 20D events
- 4.0
- Outcome status
- INSUFFICIENT_SAMPLE
Latest company: CARVOLIX
Companies: AFFLUENT MEDICAL | CARVOLIX
Post-purchase outcomes
Benchmark-relative outcomes are available against CAC 40.
- Excess return = stock return − CAC 40 return over the same period.
- Hit rate = positive excess-return events ÷ completed events.
- Price coverage = valid point-in-time prices ÷ events mature enough for that period.
- Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 4Small sample | 100.0% (4/4) | 75.0% (3/4) | +11.1% | +26.7% | -6.4% |
| 20D | 4Small sample | 100.0% (4/4) | 75.0% (3/4) | +20.3% | +25.9% | -15.6% |
| 60D | 4Small sample | 100.0% (4/4) | 75.0% (3/4) | +27.2% | +27.9% | -16.4% |
| 120D | 3Small sample | 100.0% (3/3) | 100.0% (3/3) | +94.1% | +98.8% | +72.5% |
Research patterns
- First purchase in 12M
- 1/4
- Large purchase ≥ €100k
- 2/4
- Cluster buying · 15D
- 0/4
- Buying the dip · ≥20% below prior 52W high
- 2/4
- Routine / opportunistic
- Not classifiable
Counts are profile-wide, point-in-time research labels. They never affect the insider score or ranking.
Every completed outcome is shown; n<5 is descriptive small-sample evidence and is not scored. Disclosure-level observations published on the same date may share a return path and may not be statistically independent. These results never affect the insider score or ranking.